636-00-0

6-OHDA is a catecholaminergic neurotoxin that has been used to induce dopaminergic lesions and parkinsonian symptoms as a model of Parkinson''s disease in rodents. It induces locomotor impairment in mice and loss of tyrosine hydroxylase-reactive neurons in mouse brain when administered into the substantia nigra, medial forebrain bundle (MFB), or striatum at doses of 9, 6, and 18 μg, respectively. Intracisternal administration of 6-OHDA (200 μg) decreases dopamine (Item No. 21992) and norepinephrine (Item No. 16673) levels in rat brain. It induces apoptosis in primary rat cortical cells and PC12 rat adrenal cells when used at a concentration of 50 μM. 6-OHDA (75 μM) activates caspase-3, -8, and -9 in a time-dependent manner and increases the level of intracellular reactive oxygen species (ROS) in PC12 cells and induces apoptosis in rat substantia nigra when stereotaxically injected into the right MFB.

beige to brown crystalline powder

6-Hydroxydopamine is a selective catecholaminergic neurotoxin. Studies show that 6-Hydroxydopamine can be used to create an animal model of Parkinson''s disease as it causes almost complete destruction of nigral dopaminergic neurons and their striatal terminals when injected into the substantia nigra of rats. 6-Hydroxydopamine induces apoptosis in PC12 cells.

Neurotoxin that destroys catecholaminergic terminals.

Store at 4°C;, stored under nitrogen,unstable in solution, ready to use.

[1] DAVID BLUM . Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson’s disease[J]. Progress in Neurobiology, 2001, 65 2: Pages 135-172. DOI: 10.1016/s0301-0082(01)00003-x
[2] ANDREAS HEUER . Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: Motor impairments identify extent of dopamine depletion at three different lesion sites[J]. Behavioural Brain Research, 2012, 228 1: Pages 30-43. DOI: 10.1016/j.bbr.2011.11.027
[3] G R BREESE T D T. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.[J]. Journal of Pharmacology and Experimental Therapeutics, 1970, 174 3: 413-420.
[4] BAEK SOO HAN . A distinct death mechanism is induced by 1-methyl-4-phenylpyridinium or by 6-hydroxydopamine in cultured rat cortical neurons: degradation and dephosphorylation of tau[J]. Neuroscience Letters, 2003, 341 2: Pages 99-102. DOI: 10.1016/s0304-3940(03)00173-3
[5] HIROFUMI FUJITA . Cell-permeable cAMP analog suppresses 6-hydroxydopamine-induced apoptosis in PC12 cells through the activation of the Akt pathway[J]. Brain Research, 2006, 1113 1: Pages 10-23. DOI: 10.1016/j.brainres.2006.06.079
[6] Y. HE  S. K L  T Lee. 6-Hydroxydopamine induced apoptosis of dopaminergic cells in the rat substantia nigra[J]. Brain Research, 2000, 858 1: Pages 163-166. DOI: 10.1016/s0006-8993(99)02459-2